25-09-2024 | ASO Author Reflections
ASO Author Reflections: Economics of Experience—Institutional Learning Curve of CRS-HIPEC
Authors:
Yusuf Ciftci, BS, Shannon N. Radomski, MD, Blake A. Johnson, MD, PhD, Fabian M. Johnston, MD, MHS, Jonathan B. Greer, MD
Published in:
Annals of Surgical Oncology
Login to get access
Excerpt
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is a technically complex and financially intensive procedure. Prior studies have examined the CRS-HIPEC learning curve from both an individual and institutional perspective, focusing on technical and oncologic outcomes as measures of surgical proficiency. These studies suggest a steep learning curve of 90–200 cases for CRS-HIPEC.
1‐3 However, the institutional learning curve of CRS-HIPEC has not been examined from a cost perspective. We investigated the association between financial outcomes and the institutional learning curve following implementation of a high-volume CRS-HIPEC program. …
